Current Neuro-Oncology
Volume
26 Number 17
20 August 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 17, 20 August
Latzer P, Zelba H, Battke F, Reinhardt A, Shao B, Bartsch O,
Rabsteyn A, Harter J, Schulze M, Okech T, Golf A, Kyzirakos-Feger
C, Kayser S, Pieper N, Feldhahn M, Wünsche J, Seitz C,
Hadaschik D, Garbe C, Hauser TK, la Fougère C, Biskup D,
Brooke D, Parker D, Martens UM, Illerhaus G, Blumenthal DT,
Merrell R, Lorenzo LS, Hidvégi M, de Robles P, Kebir S, Li
WW, Li VW, Williams M, Miller AM, Kesari S, Castro M, Desjardins
A, Ashley DM, Friedman HS, Wen PY, Neil EC, Iwamoto FM, Sipos B,
Geletneky K, Zender L, Glas M, Reardon DA, Biskup S.
A
real-world observation of patients with glioblastoma treated with
a personalized peptide vaccine.
Nat
Commun. 2024 Aug 11;15(1):6870. doi:
10.1038/s41467-024-51315-8. PMID:
39127809. Observational
study. ˍ
Gheorghiu A, Brunborg C, Johannesen TB, Helseth E, Zwart JA,
Wiedmann MKH.
Lifestyle and metabolic
factors affect risk for meningioma in women: a prospective
population-based study (The Cohort of Norway).
Front
Oncol. 2024 Aug 12;14:1428142. doi:
10.3389/fonc.2024.1428142. PMID:
39188673. Observational study. ˍ
Kloosterman DJ, Erbani J, Boon M, Farber M, Handgraaf SM,
Ando-Kuri M, Sánchez-López E, Fontein B, Mertz M,
Nieuwland M, Liu NQ, Forn-Cuni G, van der Wel NN, Grootemaat AE,
Reinalda L, van Kasteren SI, de Wit E, Ruffell B, Snaar-Jagalska
E, Petrecca K, Brandsma D, Kros A, Giera M, Akkari L.
Macrophage-mediated myelin recycling
fuels brain cancer malignancy.
Cell.
2024 Aug 12:S0092-8674(24)00824-9. doi:
10.1016/j.cell.2024.07.030. PMID:
39137777. Laboratory investigation. ˍ
Nakayasu S, Tanji M, Uto M, Takeuchi Y, Makino Y, Yamamoto Hattori
E, Terada Y, Sano N, Mineharu Y, Mizowaki T, Arakawa
Y.
Hypofractionated radiotherapy
combined with bevacizumab plus low-dose ifosfamide, carboplatin,
and etoposide as second-line chemoradiotherapy for progressing
spinal diffuse midline glioma, H3K27-altered: illustrative case.
J
Neurosurg Case Lessons. 2024 Aug 12;8(7):CASE2464. doi:
10.3171/CASE2464. PMID:
39133948. Case report. ˍ
Yang Y, Valdés-Rives SA, Liu Q, Gao T, Burudpakdee C, Li Y,
Tan J, Tan Y, Koch CA, Rong Y, Houser SR, Wei S, Cai KQ, Wu J,
Cheng SY, Wechsler-Reya R, Yang ZJ.
Thyroid
hormone suppresses medulloblastoma progression through promoting
terminal differentiation of tumor cells.
Cancer
Cell. 2024 Aug 12;42(8):1434-1449.e5. doi:
10.1016/j.ccell.2024.07.008.
PMID:
39137728. Laboratory investigation˰
ˍ
Elahi LS, Condro MC, Kawaguchi R, Qin Y, Alvarado AG, Gruender B,
Qi H, Li T, Lai A, Castro MG, Lowenstein PR, Garrett MC, Kornblum
HI.
Valproic acid targets IDH1 mutants
through alteration of lipid metabolism.
NPJ
Metab Health Dis. 2024 Aug 13;2(1):20. doi:
10.1038/s44324-024-00021-6. PMID:
39149696. Laboratory investigation. ˍ
Homma T, Suzuki T, Kato T, Shirahata M, Mishima K.
Cerebrospinal
fluid cytology in a case of epithelioid glioblastoma.
Cytopathology.
2024 Aug 13. doi:
10.1111/cyt.13436. PMID:
39136219. Case report. ˍ
Park JO, Feng YH, Su WC, Oh DY, Keam B, Shen L, Kim SW, Liu X,
Liao H, Qing M, Zhang C, Qian J, Tang X, Li P, Triantos S, Sweiti
H.
Erdafitinib in Asian patients with
advanced solid tumors: an open-label, single-arm, phase IIa
trial.
BMC
Cancer. 2024 Aug 13;24(1):1006. doi:
10.1186/s12885-024-12584-0. PMID:
39138436. Interventional study. ˍ
Ridolfi L, Gurrieri L, Riva N, Bulgarelli J, De Rosa F, Guidoboni
M, Fausti V, Ranallo N, Calpona S, Tazzari M, Petrini M, Granato
AM, Pancisi E, Foca F, D'Allagata M, Bondi I, Amadori E, Cortesi
P, Zani C, Ancarani V, Gamboni A, Polselli A, Pasini G, Bartolini
D, Maimone G, Arpa D, Tosatto L.
First
step results from a phase II study of a dendritic cell vaccine in
glioblastoma patients (CombiG-vax).
Front
Immunol. 2024 Aug 13;15:1404861. doi:
10.3389/fimmu.2024.1404861. PMID:
39192978. Interventional study. ˍ
Cain SA, Topp M, Rosenthal M, Tobler R, Freytag S, Best SA,
Whittle JR, Drummond KJ.
A
perioperative study of Safusidenib in patients with IDH1-mutated
glioma.
Future
Oncol. 2024 Aug 14:1-12. doi:
10.1080/14796694.2024.2383064. PMID:
39140289. Interventional study protocol.
ˍ
Dagher SA, Liu HL, Ozkara BB, Calle S, Kaya D, Gule-Monroe MK,
Chasen NN, Schellingerhout D, Learned KO, Shah KB, Johnson JM, Sun
J, Schomer DF, Kumar VA, Wintermark M, Majd NK, Nam JY, Chen MM.
The Impact of MRI-Based Advanced
Neuroimaging on Neurooncologists' Clinical Decision-Making in
Patients With Posttreatment High-Grade Glioma: A Prospective
Survey-Based Study.
AJR
Am J Roentgenol. 2024 Aug 14. doi:
10.2214/AJR.24.31595. PMID:
39140632. Observational study. ˍ
Kuehn JC, Metzger P, Neidert N, Matysiak U, Gräßel L,
Philipp U, Bleul S, Pauli T, Falkenstein J, Bertemes H, Cysar S,
Hess ME, Frey AV, Duque-Afonso J, Schorb E, Machein M, Beck J,
Schnell O, von Bubnoff N, Illert AL, Peters C, Brummer T, Prinz M,
Miething C, Becker H, Lassmann S, Werner M, Börries M,
Duyster J, Heiland DH, Sankowski R, Scherer F.
Comprehensive
genetic profiling and molecularly guided treatment for patients
with primary CNS tumors.
NPJ
Precis Oncol. 2024 Aug 14;8(1):180. doi:
10.1038/s41698-024-00674-y. PMID:
39143272. Observational study. ˍ
Pandit-Taskar N, Zanzonico PB, Grkovski M, Donzelli M, Vietri SM,
Horan C, Serencsits B, Prasad K, Lyashchenko S, Kramer K, Dunkel
IJ, Souweidane MM.
Theranostic
Intratumoral Convection-Enhanced Delivery of 124I-Omburtamab
in Patients with Diffuse Intrinsic Pontine Glioma:
Pharmacokinetics and Lesion Dosimetry.
J
Nucl Med. 2024 Aug 14:jnumed.123.266365. doi:
10.2967/jnumed.123.266365. PMID:
39142829. Observational study˰
ˍ
Rendo V, Lee EQ, Bossi C, Khuu N, Rudek MA, Pal S, Reynolds ARN,
Fassinou ACR, Ayoub G, Lapinskas E, Pisano W, Jeang J, Stopka SA,
Regan MS, Spetz J, Desai A, Lieberman F, Fisher JD, Pelton K,
Huang RY, Nabors LB, Holdhoff M, Danda N, Strowd R, Desideri S,
Walbert T, Ye X, Agar NYR, Grossman SA, Alexander BM, Wen PY,
Ligon KL, Beroukhim R.
Surgical window
of opportunity trial reveals mechanisms of response and resistance
to navtemadlin (KRT-232) in patients with recurrent glioblastoma.
medRxiv
[Preprint]. 2024 Aug 14:2024.08.12.24311893. doi:
10.1101/2024.08.12.24311893. PMID:
39211865. Interventional study. ˍ
Severi S, Grassi I, Bongiovanni A, Nicolini S, Marini I, Arpa D,
Ranallo N, Azzali I, Di Iorio V, Sarnelli A, Manuela M, Amadori E,
Fabbri L, Bartolini D, Tosatto L, Di Meco F, Gurrieri L, Riva N,
Calabro L, Matteucci F, Paganelli G, Sansovini M.
Peptide
Receptor Radionuclide Therapy in Advanced Refractory Meningiomas:
Efficacy and Toxicity in a Long Follow-up.
J
Nucl Med. 2024 Aug 14:jnumed.123.266956. doi:
10.2967/jnumed.123.266956. PMID:
39142827. Observational study. ˍ
Lee MD, Jain R, Galbraith K, Chen A, Lieberman E, Patel SH,
Placantonakis DG, Zagzag D, Barbaro M, Guillermo Prieto Eibl MDP,
Golfinos JG, Orringer DA, Snuderl M.
T2-FLAIR
Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B
Status in IDH-Mutant Astrocytomas.
Clin
Cancer Res. 2024 Aug 15;30(16):3512-3519. doi:
10.1158/1078-0432.CCR-24-0311. PMID:
38829583. Observational study˰
ˍ
Lorincz KN, Gorodezki D, Schittenhelm J, Zipfel J, Tellermann J,
Tatagiba M, Ebinger M, Schuhmann MU.
Role
of surgery in the treatment of pediatric low-grade glioma with
various degrees of brain stem involvement.
Childs
Nerv Syst. 2024 Aug 15. doi:
10.1007/s00381-024-06561-y. PMID:
39145885. Observational
study. ˍ
Batool SM, Escobedo AK, Hsia T, Ekanayake E, Khanna SK, Gamblin
AS, Zheng H, Skog J, Miller JJ, Stemmer-Rachamimov AO, Cahill DP,
Balaj L, Carter BS.
Clinical utility of
a blood based assay for the detection of IDH1.R132H-mutant
gliomas.
Nat
Commun. 2024 Aug 16;15(1):7074. doi:
10.1038/s41467-024-51332-7. PMID:
39152110. Observational
study. ˍ
Mullard A.
FDA approves IDH1 and IDH2
inhibitor for brain cancer.
Nat Rev Drug Discov. 2024
Aug 16. doi:
10.1038/d41573-024-00135-y. PMID:
39152244. News˰ ˍ
Martinez I, Currie E, Davis ES, Kumar R, Lawhon V, Snaman JM,
Tefera RB, Bhatia S, Rosenberg AR, Johnston EE.
Bereaved
parent preferences on quality end-of-life care for children with
cancer in the South.
Cancer.
2024 Aug 18. doi:
10.1002/cncr.35518. PMID:
39155428. Observational
study˰ ˍ
Shen L, Li S, Wang Y, Yin Y, Liu Y, Zhang Y, Zheng X.
Alternating
electric fields transform the intricate network of tumour
vasculature into orderly parallel capillaries and enhance the
anti-angiogenesis effect of bevacizumab.
Cell
Prolif. 2024 Aug 19:e13734. doi:
10.1111/cpr.13734. PMID:
39161078. Laboratory investigation. ˍ
Willis KD, Reid MP, Fox A, Kleva CS, Sherwood P, Loughan AR.
The
impact of a primary brain tumor diagnosis on caregivers: Insights
from the patients' perspective.
Support
Care Cancer. 2024 Aug 19;32(9):595. doi:
10.1007/s00520-024-08783-x. PMID:
39160352. Observational
study. ˍ
Li W, Wang Z, Chen S, Liu Y.
Glioblastoma
concurrent with follicular lymphoma: A case report.
Asian
J Surg. 2024 Aug 20:S1015-9584(24)01715-9. doi:
10.1016/j.asjsur.2024.07.341. PMID:
39168739. Case report. ˍ
Soeung V, Puchalski RB, Noebels JL.
The
complex molecular epileptogenesis landscape of glioblastoma.
Cell
Rep Med. 2024 Aug 20;5(8):101691. doi:
10.1016/j.xcrm.2024.101691. PMID:
39168100. Laboratory investigation. ˍ